Therapeutics
Börse Express – IRW-News: Defence Therapeutics Inc.: Defence to attend the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024
IRW-PRESS: Defence Therapeutics Inc.: Defence to attend Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024 Vancouver, British Columbia, Canada, June 10, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”) (CSE: DTC, OTCQB: DTCFF, Frankfurt Stock Exchange: DTC), a Canadian biopharmaceutical company developing novel immuno-oncology therapeutics and drug […]
Atossa Therapeutics Announces Expanded Research Agreement
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced an expanded research agreement with Weill Cornell Medicine to explore the potential synergy between antibody drugs conjugates (ADCs) and (Z)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need […]